H World Group Limited American Depositary Shares vs Novartis AG — how do they compare? H World Group Limited American Depositary Shares trades at $43.59 (market cap $13.30B), while Novartis AG trades at $142.74 (market cap $274.00B). The key difference: Novartis AG is far larger — about 20.6× H World Group Limited American Depositary Shares's market cap, and H World Group Limited American Depositary Shares pays the higher dividend (5.18%). Which is the better fit depends on your goals — on Pluang, investors hold H World Group Limited American Depositary Shares for 0 Days and Novartis AG for 82 Days on average.
| HTHT | NVS | |
|---|---|---|
Market Cap | $13.30B | $274.00B |
Volume | 503,353 | 1,852,137 |
Sector | Consumer Cyclical | Health |
52-Week High | $56.06 | $168.62 |
52-Week Low | $36.99 | $121.80 |
Typical Hold Time | 0 Days | 82 Days |
Enterprise Value | $16.09B | $315.32B |
Dividend Yield | 5.18% | 3.31% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novartis (NVS) trades at $143.28, up 1.77% today, with mixed technical signals showing neutral momentum. The company demonstrates strong fundamentals with $56.67B revenue in 2025, 22.5% net margin, and consistent earnings beats in recent quarters. Recent developments include a significant $7.8B licensing deal with China's Abogen for mRNA therapy, though offset by clinical trial setbacks in ALS drug development and ongoing investor scrutiny of M&A strategy.
Outlook remains cautiously optimistic with analyst consensus target of $146 suggesting modest upside. Key opportunities include pipeline expansion through strategic partnerships, while risks involve clinical trial failures, M&A integration challenges, and patent cliff pressures. The stock presents a balanced risk-reward profile with strong profitability offset by pipeline execution concerns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.
Read more on HTHT →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →